Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)

Saved in:
Bibliographic Details
Published in:Lung Cancer: Targets and Therapy
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301672820146177
collection WordPress RSS
FRELIP Feed Integration
container_title Lung Cancer: Targets and Therapy
description
discipline_display Respiratory Diseases
discipline_facet Respiratory Diseases
format Online Article
RSS Article
genre Journal Article
id rss_article:58422
institution FRELIP
journal_source_facet Lung Cancer: Targets and Therapy
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)
Respiratory Diseases
General
Respiratory Diseases
sub_discipline_display General
sub_discipline_facet General
subject_display Respiratory Diseases
General
Respiratory Diseases
Respiratory Diseases
General
Respiratory Diseases
subject_facet Respiratory Diseases
General
Respiratory Diseases
title Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)
title_auth Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)
title_full Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)
title_fullStr Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)
title_full_unstemmed Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)
title_short Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)
title_sort alectinib efficacy post-brigatinib against advanced alk+ non-small cell lung cancer (brigalk2-gfpc 02-2019 study)
topic Respiratory Diseases
General
Respiratory Diseases
url https://www.dovepress.com/alectinib-efficacy-post-brigatinib-against-advanced-alk-non-small-cell-peer-reviewed-fulltext-article-LCTT